Bain Capital Public Equity Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Bain Capital Public Equity Management’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-50,541	Closed	-$2.3M	–	81
2018 Q2	$2.3M	Sell	50,541 -1,959	-4%	-$95.3K	0.16%	50
2018 Q1	$2.77M	Buy	+52,500	New	+$3.06M	0.2%	48
2017 Q4	–	Sell	-211,851	Closed	-$14.8M	–	107
2017 Q3	$17.5M	Buy	211,851 +71,293	+51%	+$5.65M	1.1%	28
2017 Q2	$13.2M	Buy	140,558 +94,658	+206%	+$5.79M	0.79%	31
2017 Q1	$2.92M	Buy	+45,900	New	+$2.79M	0.21%	53

Other funds holding CLVS

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Bain Capital Public Equity Management's CLVS Position: Q3 2018 in Review

Bain Capital Public Equity Management sold out of Clovis Oncology, Inc. (CLVS) in Q3 2018, closing a stake of 50,541 shares — an estimated $2.3M sold.

Bain Capital Public Equity Management first reported a position in CLVS in Q1 2017 and held it in 5 quarters. The position peaked at $17.5M in Q3 2017. 192 funds tracked by Wall St. Rank hold CLVS as of Q3 2018.

Bain Capital Public Equity Management reported no remaining Clovis Oncology, Inc. position as of Q3 2018 after selling out during the quarter.
Bain Capital Public Equity Management sold 50,541 Clovis Oncology, Inc. shares in Q3 2018, an estimated $2.3M.
Bain Capital Public Equity Management first reported a position in Clovis Oncology, Inc. in Q1 2017 and held it in 5 quarters.
Bain Capital Public Equity Management's Clovis Oncology, Inc. position peaked at $17.5M in Q3 2017.
192 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2018.

Based on Bain Capital Public Equity Management's 13F filing for Q3 2018, filed 14 Nov 2018.